ATE393216T1 - Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln - Google Patents

Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln

Info

Publication number
ATE393216T1
ATE393216T1 AT97925652T AT97925652T ATE393216T1 AT E393216 T1 ATE393216 T1 AT E393216T1 AT 97925652 T AT97925652 T AT 97925652T AT 97925652 T AT97925652 T AT 97925652T AT E393216 T1 ATE393216 T1 AT E393216T1
Authority
AT
Austria
Prior art keywords
catalysts
formulations
cross
organic solvents
linked protein
Prior art date
Application number
AT97925652T
Other languages
German (de)
English (en)
Inventor
Nazer Khalaf
Original Assignee
Altus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altus Pharmaceuticals Inc filed Critical Altus Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE393216T1 publication Critical patent/ATE393216T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97925652T 1996-05-24 1997-05-20 Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln ATE393216T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/652,964 US5932212A (en) 1996-05-24 1996-05-24 Crosslinked protein crystal formulations and their use as catalysts in organic solvents

Publications (1)

Publication Number Publication Date
ATE393216T1 true ATE393216T1 (de) 2008-05-15

Family

ID=24618946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97925652T ATE393216T1 (de) 1996-05-24 1997-05-20 Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln

Country Status (13)

Country Link
US (2) US5932212A (forum.php)
EP (1) EP0906417B1 (forum.php)
JP (2) JP4279351B2 (forum.php)
KR (1) KR20000015993A (forum.php)
AR (1) AR007211A1 (forum.php)
AT (1) ATE393216T1 (forum.php)
AU (1) AU3072897A (forum.php)
DE (1) DE69738648T2 (forum.php)
DK (1) DK0906417T3 (forum.php)
ID (1) ID17817A (forum.php)
IN (1) IN191060B (forum.php)
WO (1) WO1997044445A1 (forum.php)
ZA (1) ZA974325B (forum.php)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009750A1 (en) * 1990-11-29 1992-06-11 Willis Richard R Floating contaminant containment systems
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US6350609B1 (en) * 1997-06-20 2002-02-26 New York University Electrospraying for mass fabrication of chips and libraries
US6833275B1 (en) * 1997-07-22 2004-12-21 Roche Diagnostics Gmbh Gold conjugates containing detergent
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
AU8772498A (en) * 1997-09-05 1999-03-29 Altus Biologics Inc. Carbohydrate crosslinked glycoprotein crystals
MY131805A (en) * 1997-09-18 2007-09-28 Biogen Idec Inc Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis.
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
EP1073421A1 (en) * 1998-04-27 2001-02-07 Altus Biologics Inc. Stabilized protein crystals, formulations containing them and methods of making them
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
CA2346702C (en) * 1998-10-09 2012-05-29 Altus Biologics Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
WO2001012834A1 (en) * 1999-08-18 2001-02-22 Hydrios Biotechnology Oy Process for the preparation and simultaneous separation of enzyme-catalysed products
US20040014195A1 (en) * 1999-12-29 2004-01-22 Diversa Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7608445B1 (en) 1999-12-29 2009-10-27 Verenium Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7521216B2 (en) * 1999-12-29 2009-04-21 Verenium Corporation Nitrilases and methods for making and using them
US7300775B2 (en) * 1999-12-29 2007-11-27 Verenium Corporation Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
EP1292823A1 (en) * 2000-05-23 2003-03-19 Radiometer Medical A/S A sensor membrane, a method for the preparation thereof, a sensor and a layered membrane structure for such sensor
AU2002256971B2 (en) * 2000-12-28 2008-04-03 Altus Pharmaceuticals Inc. Crystals of whole antibodies and fragments thereof and methods for making and using them
JP2005500304A (ja) 2001-06-21 2005-01-06 アルタス バイオロジックス インコーポレイテッド 球状タンパク質粒子およびそれらの作製方法および使用方法
WO2003106415A2 (en) 2002-06-13 2003-12-24 Diversa Corporation Processes for making (r)-ethyl 4-cyano-3-hydroxybutyric acid
US9035123B2 (en) 2002-10-01 2015-05-19 The Procter & Gamble Company Absorbent article having a lotioned topsheet
BR0317896A (pt) * 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Complexos de cristais de proteìna e polìmeros iÈnicos
SG176314A1 (en) * 2002-12-31 2011-12-29 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
WO2005066341A1 (en) * 2004-01-01 2005-07-21 Council Of Scientific & Industrial Research A method for the preparation of cross linked protein crystals
EP2198880B1 (en) * 2004-10-14 2016-11-23 Eli Lilly And Co. Compositions containing lipase, protease and amylase for treating pancreatic insufficiency
WO2007050100A2 (en) * 2004-11-24 2007-05-03 Industrial Science & Technology Network, Inc. Immobilized enzymes and processes for preparing and using same
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
AU2006330833A1 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
WO2008034082A2 (en) * 2006-09-15 2008-03-20 Maroon Biotech, Corporation Method of using amphiphilic multiblock copolymers in food
EP2115153B1 (en) 2007-03-01 2013-06-05 BP Corporation North America Inc. Nitrilases, nucleic acids encoding them and methods for making and using them
IL183084A0 (en) * 2007-05-09 2007-09-20 Trans Biodisel Ltd Modified-immobilized enzymes of high tolerance to hydrophilic substrates in organic media
CN101717766B (zh) * 2009-12-01 2012-07-18 暨南大学 蛋白质酶的微水介质固定化方法
CA2803959C (en) 2010-06-30 2021-01-19 Codexis, Inc. Chemically modified carbonic anhydrases useful in carbon capture systems
WO2012026493A1 (ja) * 2010-08-26 2012-03-01 アイシン精機株式会社 酵素結晶固定化電極及び酵素結晶固定化電極の製造方法、並びに酵素結晶固定化電極を備えるバイオ電池及びバイオセンサー

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267234A (en) * 1978-03-17 1981-05-12 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US4369226A (en) * 1979-03-19 1983-01-18 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US5152903A (en) * 1988-12-19 1992-10-06 American Cyanamid Company Cross-linked cationic polymeric microparticles
DK0861888T3 (da) * 1990-08-03 2006-08-14 Vertex Pharma Anvendelse af tværbundne krystaller som en ny form for immobilisering af enzymer
GB9309243D0 (en) * 1993-05-05 1993-06-16 Allied Colloids Ltd Enzyme dispersions,their production and compositions containing them
US5773266A (en) * 1993-05-20 1998-06-30 Loders-Croklaan B.V. Immobilized lipases on a dry, porous particulate hydrophobic support and containing a non-ionic surfactant
ATE193319T1 (de) * 1993-12-03 2000-06-15 Buckman Labor Inc Enzymstabilisierung durch blockcopolymere
DE4344211A1 (de) * 1993-12-23 1995-06-29 Basf Ag Verfahren zur Erhöhung der Aktivität von hydrolytischen Enzymen

Also Published As

Publication number Publication date
JP2000514282A (ja) 2000-10-31
WO1997044445A1 (en) 1997-11-27
JP4279351B2 (ja) 2009-06-17
US5932212A (en) 1999-08-03
DE69738648D1 (de) 2008-06-05
ID17817A (id) 1998-01-29
KR20000015993A (ko) 2000-03-25
AU3072897A (en) 1997-12-09
DE69738648T2 (de) 2009-05-28
ZA974325B (en) 1997-12-18
US6042824A (en) 2000-03-28
JP2008061652A (ja) 2008-03-21
DK0906417T3 (da) 2008-07-21
AR007211A1 (es) 1999-10-13
IN191060B (forum.php) 2003-09-13
EP0906417B1 (en) 2008-04-23
EP0906417A1 (en) 1999-04-07

Similar Documents

Publication Publication Date Title
ATE393216T1 (de) Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln
DE59712887D1 (de) Substituierte phenylketoenole und ihre verwendung als schädlingsbekämpfungsmittel
DE69511860D1 (de) Modifizierung von clostridium-toxinen und ihre anwendung als transport proteine
DE59812907D1 (de) Substituierte Isochinolin-3-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE69826662D1 (de) 4-brom or 4-iod-phenylamino-benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
ATE202347T1 (de) Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren
DE69720389D1 (de) Zementzusammensetzungen und ihre Verwendung
DE69836346D1 (de) Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
ATE227266T1 (de) Aromatische c16-c20-substituierte tetrahydro- prostaglandine und ihre verwendung als prostaglandin f agonisten
DE59706602D1 (de) 3-Hydroxy-Pyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
DE69718791D1 (de) Neuartige aminosäurederivate und deren verwendung als thrombininhibitoren
DE59804276D1 (de) Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
DE69716896D1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DE69825202D1 (de) Kautschukzusammensetzung und ihre Verwendung in Reifen
DE69620914D1 (de) Perfluoralkoxycycloalkancarbonylfluorid-zusammensetzungen und ihre verwendung
DE69822509D1 (de) Zusammensetzung von alditol-acetalen und ihrer verwendung
DE59701610D1 (de) Verwendung von sarkosinaten als asphalten-dispergatoren
ATE209626T1 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
DE59711049D1 (de) Kosmetisches Hautbräunungs- und Lichtschutzmittel
DE69832902D1 (de) Oromukosal-zytokin-zusammensetzungen und ihre verwendung
DE69728938D1 (de) Peptidantagonisten der zellulären mitogenese und motogenese und deren therapeutische verwendung
EP1073458A4 (en) CHLAMYDIA PROTEINS AND USES THEREOF
DE69706128D1 (de) Estermischung und ihre verwendung
NO990806L (no) Biologisk nedbrytning av eksplosiver

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties